GRAYSLAKE – Illinoisans with diabetes will receive relief from skyrocketing insulin prices at the turn of the year thanks to a measure co-sponsored by State Senator Melinda Bush (D-Grayslake).

“No person should be forced to skip a meal or default on their mortgage just to be able to afford a medication they need to live,” Bush said. “The cap on rising insulin costs will protect people with diabetes and their families.”

Senate Bill 667 — which takes effect Jan. 1 — caps patients’ out-of-pocket costs for prescription insulin at $100 for a 30-day supply.

More than 30 million Americans have diabetes, and 7.4 million Americans require prescription insulin every day to survive, according to the American Diabetes Association. However, the price of insulin has risen sharply in recent years, driving many patients to give up other daily needs to pay for insulin or to ration their supply.

“People will no longer have to take shortcuts or seek out other ways to get their hands on insulin,” Bush said. “The days of prescription drug companies prioritizing profit over people must come to an end — and that starts with this new law.”

The measure makes Illinois the second state to cap prescription insulin co-payments.